WT1/IL15/IL15Ra mRNA DC clinical trials

First-in-human interleukin-15-transpresenting Wilms’ tumor protein 1-targeting autologous dendritic cell vaccination in cancer patients

This study is testing a new vaccine for advanced cancers like pancreatic, liver, or ovarian cancer. It uses your own immune cells to create a special vaccine that targets cancer. This early study aims to see if the vaccine is safe, can be made successfully, and how it affects the cancer and your immune system.